Blin, P., Dureau‐Pournin, C., Cottin, Y., Bénichou, J., Mismetti, P., Abouelfath, A., . . . Moore, N. (2018). Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation. Br J Clin Pharmacol.

Blin, Patrick, Caroline Dureau‐Pournin, Yves Cottin, Jacques Bénichou, Patrick Mismetti, Abdelilah Abouelfath, Regis Lassalle, Cécile Droz, och Nicholas Moore. "Effectiveness and Safety of 110 or 150 mg Dabigatran Vs. Vitamin K Antagonists in Nonvalvular Atrial Fibrillation." Br J Clin Pharmacol 2018.

Blin, Patrick, et al. "Effectiveness and Safety of 110 or 150 mg Dabigatran Vs. Vitamin K Antagonists in Nonvalvular Atrial Fibrillation." Br J Clin Pharmacol 2018.